Currently, cagrilintide remains investigational and available only as a research chemical while awaiting FDA approval expected 2025-2026
Brett Osborn, a Florida neurologist and longevity expert, agreed that the availability of the first generic GLP-1 is "great news." The generics lower price point is particularly beneficial for people who have chronic conditions like diabetes, Osborn noted "where long-term medication use is necessary to prevent downrange effects like vascular disease, strokes and heart attacks , cancer, neurodegenerative diseases like Alzheimers, and obesity, the latter of which is also a gateway disease," he said
International Journal of Molecular Sciences , 26(8), 3632.
[ 1 ] Doing so would allow researchers to have a more stable and standardized compound that was associated with some of the biological effects from the natural pineal extract